Loading...

University of Hong Kong medical school to revamp training programme

Image

11-Oct-16 Hong Kong’s most prominent medical school will revamp its training programme for medical students to give them more comprehensive training not only in public wards, but also for the first time in a new private teaching hospital and a related facility in Shenzhen. [image: South China Morning Post]

Read More

China's Fosun eyes Brazil hospital deals

Image

05-Oct-16 Chinese conglomerate Fosun International is in advanced talks to acquire Hospital da Bahia, a Brazilian hospital in the city of Salvador, for about BRL1 bn (USD308 mn). Brazilian business daily Valor Economico reported that Fosun is also looking to spend an additional BRL2 bn on other acquisitions to form a Brazilian hospital chain. [image: Fosun International Ltd]

Read More

Intuitive Surgical teams with Chinese company on lung cancer

Image

03-Oct-16 Intuitive Surgical is expanding into robotic-assisted catheter-based medical devices through a JV with Shanghai Fosun Pharmaceutical. These devices will use IP from Intuitive Surgical and will focus on diagnosis and treatment of lung cancer. R&D and manufacturing will take place in Shanghai. Intuitive Surgical will oversee distribution outside China while the JV will be in charge within China. [image: Asian Scientist Magazine]

Read More

Singapore medical group expanding in China

Image

02-Oct-16 A pioneering Singapore fertility expert will head efforts to help Chinese women who find it hard to conceive, by setting up medical centres in China. They set up their first in Xiamen two years ago, and will open a centre in Chengdu by Dec-15. "We hope to expand into a network of 600 satellite women's clinics," said CEO Ms Bi. [image: Chew Seng Kim / ST]

Read More

80% of data in Chinese clinical trials fabricated

Image

01-Oct-16 A Chinese government investigation has revealed that more than 80% of the data used in clinical trials of new drugs have been "fabricated". The investigation, led by the SFDA, looked at data from 1,622 clinical trials. The SFDA found that the suspect data failed to meet analysis requirements, were incomplete, or totally non-existent. [image: Plavevski / Shutterstock / Science Alert]

Read More
Share